May
20
2013
Zohydro News Update: New Delay
I was really hoping that the next time I blogged about Zohydro, it would be to announce the fate of this much-publicized painkiller—whether it had been approved or rejected by the Food and Drug Administration (FDA).
I certainly did not anticipate writing how Zohydro’s approval date has been pushed back yet again. But it’s true.
Originally scheduled for March 1, a press release from late last month announced that the FDA needed a few more weeks to decide. The FDA did not provide any reason for the possible delay, except for saying that the delay ... Read More →